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CLINICAL RELEVANCE 
 
Scientific rationale for the study: Collagen matrices (CM) were developed to increase the 
width of keratinized tissue around teeth and implants. This study presents the histologic 
analysis of the early healing of a xenogeneic collagen matrix (XCM) compared to a 
spontaneously healing experimental wound.  
Principal findings: At 4 and 8 days, the extent of the epithelial coverage was slightly 
greater for XCM sites than for control sites. Furthermore, at 4 days and at 8 days after 
surgery there was a lower amount of granulation tissue found at XCM sites. At 15 days, 
all experimental wounds presented a fully keratinized epithelium.  
Practical implications: The use of a xenogeneic collagen matrix as a palatal wound 
dressing may offer an accelerated wound healing at the early stages. 
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ABSTRACT 
 
Aim: To test whether or not a collagen matrix can improve early wound healing 
compared to spontaneous healing based on histologic and immunohistologic analyses. 
Methods: In 20 volunteers, 6 mm punch biopsies were harvested at the palate. A 
xenogeneic collagen matrix (XCM) was sutured in one site; the other one was left 
untreated (control). Biopsies with a diameter of 8 mm were subsequently obtained at 4, 
8, 15 and 29 days and histologic and immunohistologic analyses were performed. 
Results: At day 4, wound bed keratinization amounted to 12.4%±7.5% (control) and 
18.0%±10.2% (XCM). This increased up to day 8 (19.7%±25.5% control; 29.1%±8.0% 
XCM) and reached complete keratinization at day 15 in both groups. The quantitative 
analyses of the superficial compartment measured an increase of the amount of 
granulation tissue (32% to 88% control; 14% to 41% XCM) from day 4 to day 8. 
Angiogenesis was first detected at 8 days. At day 29, the amount of connective tissue in 
all compartments reached values similar to the native tissue at baseline. 
Conclusions: The application of a xenogeneic collagen matrix (XCM) as a wound 
dressing on palatal wounds might be beneficial in the early stages of wound healing. 
Further research with a larger sample size is needed to confirm these results. 
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INTRODUCTION 
Soft tissue grafting procedures are routinely performed for a variety of clinical indications 
in implant and reconstructive dentistry (Kim and Neiva, 2015). According to recent 
systematic reviews, the use of autogenous tissue harvested from the retromolar or 
palatal area is considered to be the gold standard around teeth and dental implants in 
partially edentulous patients (Thoma et al., 2014, Thoma et al., 2009, Levine et al., 
2014, Cairo et al., 2014). Whereas these transplants and techniques are well 
documented, disadvantages are often reported, mostly due to the morbidity associated 
with the harvesting procedure and the respective second surgical site (Griffin et al., 
2006, Wessel and Tatakis, 2008, Harris et al., 2005). In order to overcome these 
drawbacks, a number of soft tissue substitutes, predominantly derived from other 
medical fields, were introduced in dentistry (Liu et al., 2010). Namely collagen matrices 
made of collagen type I and III have been the field of interest in recent years. These 
substitute materials were evaluated in preclinical and clinical studies for gain of 
keratinized tissue around teeth and implants, for recession coverage, for ridge 
preservation and even for soft tissue volume gain (Schmitt et al., 2015, Rotundo and 
Pini-Prato, 2012, Nevins et al., 2011, Lorenzo et al., 2012, Jung et al., 2013b, Thoma et 
al., 2010, Cardaropoli et al., 2012). The currently available evidence suggests that these 
collagen matrices can be safely used, integrate well into surrounding tissue, increase 
tissue thickness and increase the width of keratinized tissue to an extent close to the 
gold standard, the autogenous tissue (Sanz et al., 2009, Thoma et al., 2012, Jung et al., 
2011, Simion et al., 2012). The most often-used collagen matrix is designed for open 
healing. It consists of a loose matrix body specifically designed of reconstituted collagen 
fibers that should help to stabilize the blood clot and enhance connective tissue 
formation, whereas the superficial layer that is constituted of native collagen fibers is 
denser and is intended to enhance the migration of epithelial cells migrating from the 
border of the augmented site. This design is theoretically ideal and supported by 
preclinical and clinical data demonstrating the establishment of keratinized tissue in sites 
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where collagen matrices are placed for open healing (Jung et al., 2011, Thoma et al., 
2012, Schmitt et al., 2013). However, human histologic data are missing in terms of i) 
the early phases of healing using collagen matrices and, ii) possible advantages of using 
collagen matrices compared to spontaneous healing. 
The aim of the present study was therefore to test whether or not a xenogeneic collagen 
matrix can improve early wound healing compared to spontaneous healing based on 
histologic and immunohistologic analyses. 
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MATERIALS AND METHODS 
 
Study design 
The present study was performed as a randomized, controlled clinical trial using a split-
mouth design. Following approval by the local ethics committee (Canton of Zurich, 
Zurich, Switzerland, KEK-ZH-Nr. 2011-0048), 20 volunteers (V1-20) were recruited and 
informed consent was obtained from all volunteers prior to the investigation. 
Subsequently, all volunteers were randomly allocated to one of four groups (V1-5 = 
primary endpoint at 4 days; V6-10 = at 8 days; V11-15 = at 15 days; V16-20 = at 29 
days) according to a computer-generated randomization list. The study procedures were 
described in detail in a previous publication (Thoma et al., 2012). 
Surgical procedures 
On each side of the palate, two punch biopsies (diameter 6 mm; depth 3 mm) were 
harvested in all volunteers (V1-20) using a digitally designed stent (SMOP by 
Swissmeda, Swissmeda AG, Zurich, Switzerland) and a biopsy punch (Stiefel® Biopsy 
Punch, Stiefel Laboratorium GmbH, Offenbach am Main, Germany), leaving the 
periosteum and part of the submucosa exposed (Figure 1 a). 
The following two treatment modalities were then randomly applied to the defect sites 
according to a computer-generated randomization list: 
- Wound closure with a xenogeneic collagen matrix (XCM; Geistlich Mucograft®, 
Geistlich Pharma AG, Wolhusen, Switzerland) with a diameter of 6 mm and a 
thickness of 3 mm. The XCM was sutured with non-resorbable sutures (Dafilon 6-
0, Braun, Melsingen, Germany) (Figure 1 b). 
- Spontaneous healing, no further treatment (control). The defect was left to heal 
by secondary intention. 
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The postoperative regimen included medication with an analgesics (Mefenamic acid, 500 
mg every 8 hours) and a disinfectant solution (Chlorhexidine digluconate, 0.2 % 
solution for oral rinsing every 8 hours for a period of 7 days). An individualized soft 
protective splint that completely covered the hard palate was given to all volunteers. 
Volunteers were instructed to use the splint during the first night to prevent bleeding 
and subsequently on an individual basis in case they felt pain. Sutures were removed at 
8 days. 
Follow-up 
At 4, 8, 15 and 29 days post surgery, all participants were recalled. According to the 
randomization schedule with 5 volunteers at each time-point, a second biopsy (diameter 
8 mm; depth 5mm) was harvested using an additional digitally designed stent. For 
volunteers 6-20, sutures were removed at 8 days. 
All harvested biopsies were subjected to further histologic processing.  
Histologic processing 
After fixation, each sample was dehydrated in alcohol solutions of increasing 
concentration and embedded in paraffin. Embedded samples were cut at 2-3 µm thick 
slides using a microtome. Four sections per block were prepared: one slide was stained 
with van Gieson-elastica (VG-EL) for overall histological evaluation, three positive 
charged sections were used for immunohistochemical analyses.  
Histologic and histomorphometric analyses 
All histological sections (VG-El) were evaluated using a Leica microscope (Leica DM6000 
B, Wetzlar, Germany) for qualitative histological analysis. For histomorphometrical 
analysis, histological images were analyzed with a software program (Adobe Photoshop 
CS6). The selected region of interest (ROI) was divided into a superficial, central and 
apical compartment (Figure 2). 
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Immunohistochemical analysis 
Immunohistochemical analysis was performed to detect tissue remodeling and 
angiogenesis. Antibodies against mouse anti Vimentin (Clone Vim3B4; DAKO M3503, 
Switzerland), mouse anti Cytokeratin (Clone MNF116; DAKO M082101, Switzerland) and 
rabbit anti Factor VIII (DAKO A0082, Switzerland) (Figure 3) were used for antigen 
detection. As secondary antibody the DAKO REAL kit (K4005 HRP, Mouse AEC+ and 
K4009 HRP, Rabbit AEC+, DAKO, Switzerland) was used. Red staining (AEC 3-amino-9-
ethylcarbazole) indicated the presence of the protein. Positive and negative control 
sections were implemented. The negative control was achieved staining the slide 
without treatment of the primary antibody in order to evaluate false positive staining. 
Vimentin was used to detect mesenchymal cells like fibroblasts that form new collagen, 
cytokeratin to detect epithelial cells of the mucosa and factor VIII (von Willebrandt 
factor) to detect endothelial cells and therefore angiogenesis. 
Thickness of keratin layer and degree of epithelialization 
The thickness of the keratin layer in the defect area was categorized according to the 
following scale: regular = >5 layers, medium = 3-5 layers, thin (<3 layers) or absence 
of epithelium. Subsequently, linear measurements were performed calculating the 
surface each category occupied. Keratinization was considered if at least 3 layers of 
were present (medium and regular). One masked experienced examiner performed all 
the measurements. 
Quantitative analyses of regenerated tissue 
The following parameters were assessed as area percentages in a defined region of 
interest: i) epithelium (EP); ii) loose connective tissue (LCT); iii) dense connective tissue 
(DCT); iv) new formed granulation tissue (GT); v) fatty tissue (FT) vi) remaining 
collagen matrix material (rXCM); vii) background, any other remaining tissue within the 
region of interest. 
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Statistical analysis  
Descriptive statistics (means and standard deviations) were computed for the control 
and XCM sites, as well as for the difference between control and XCM values, at each 
time point and for each variable studied. No specific statistical tests were made due to a 
relatively low sample size and an increased number of volunteers  compared to the 
previously published study including clinical patient-reported outcome measures (Thoma 
et al., 2012). 
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RESULTS 
All volunteers completed the study and neither systemic nor local side effects were 
noted during the entire study period. Biopsies in all volunteers were harvested, 
processed and could be used for analyses. 
Descriptive histology and immunohistochemical analysis 
The native, preoperatively obtained biopsies, revealed a continuous keratinized 
epithelium with long rete pegs, the subepithelial connective tissue was dense, regularly 
and horizontally arranged. Occasionally, a low number of lymphocytes and plasma cells 
were visible (Figure 4). The cytokeratin staining of the epithelium and the vimentin 
staining of the native subepithelial tissue were strong and even. In the factor VIII 
staining only few blood vessels were visible. 
At day 4, the original defect site was clearly visible and on the borders the preexisting 
epithelium remained (Figure 5 a+b). The wound bed was characterized by a central 
concavity. The borders towards the surrounding native dense connective tissue were 
distinct. The defect area itself was predominantly occupied by moderate to large 
amounts of neutrophils and covered as well as interspersed by fibrin and acute 
bleedings. The cytokeratin staining was visible on the edges on the remaining 
epithelium and the vimentin staining and the Factor VIII staining were negative in these 
lesions. In XCM sites, the collagen matrix network was admixed with the fibrin. 
At day 8, the original defect was still visible, but on the edges the epithelium was 
beginning to grow over the defect as a thin layer with elongated epithelial cells. 
Keratinization was not fully established, even though some epithelial layers were 
present (≤2 layers). The remaining part of the defect was filled by loose and sometimes 
strongly edematous young granulation tissue admixed with activated vessels, serous 
fluid and fibrin. A moderate to strong infiltration with neutrophils was observed. In case, 
the neutrophilic inflammation was strong, the granulation tissue was loose and less 
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developed compared to the lesions with fewer neutrophils. The vessels were oriented 
90° to the defect site. In general, the control sites had more granulation tissue 
formation than XCM sites. Formation of epithelium was observed at the borders of the 
defect areas. In some sites, the transition between the native tissue and the newly 
formed tissue at the former biopsy site was not as smooth (Fig. 5c). In other sites, the 
transition was more continuous (Fig. 5d). Differences between test and control sites 
were difficult to detect. The epithelium at the borders and the preexisting epithelium 
were strongly positive in the cytokeratin staining. The vimentin staining was only faintly 
positive in the defect area demonstrating no new collagen formation up to this time-
point in both groups. The neutrophils were also positive in the vimentin staining. The 
activated and newly formed vessels expressed Factor VIII. The factor VIII staining 
showed more blood vessels close to the epithelium than in the underlying connective 
tissue and a larger number in XCM (Fig. 3a) than in control sites (Fig. 3b). 
At day 15, the defect area was covered by a thicker epithelium compared to the native 
biopsies taken at day 0, showing irregular and misshapen rete pegs (longer and/or 
shorter and/or thicker) but already keratinization. The borders of the original wound 
were still visible, even though much less distinct. Great parts of the wound were 
replaced by a loose to dense connective tissue with a high number of blood vessels 
arranged 90° to the former defect (granulation tissue). The loose connective tissue 
merged into the underlying native dense connective tissue. Intermingled in the 
granulation tissue a high amount of lymphocytes, few neutrophils and less plasma cells 
and eosinophils were visible. The XCM network could not be differentiated from the 
collagen fibers of the newly formed connective tissue at this time-point (Figure 5 e+f). 
The XCM sites had a more pronounced inflammatory reaction than control sites. The 
cytokeratin staining of the epithelium was strong as was the staining of the connective 
tissue, but in a denser way than in the control sites.  
At day 29, the maturation had continued in both, the spongeous part and the superficial 
layer. Therefore, the borders of the original defect could hardly be identified. A shift had 
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occurred and transformed the loose into a slightly dense granulation tissue with a lower 
number of newly formed blood vessels than at day 15. However, the vessels were more 
prominent. The vessels were beginning to orient horizontally to the epithelium. Still, the 
density of the connective tissue did not catch up yet with the one from the preoperative 
time-point. At the epithelial layer, rete pegs had become more numerous and similar in 
dimension compared to the mature native tissue at least at the lateral aspects. The 
keratin layer reached dimensions almost similar to the original preoperative time-point. 
In the control sites, no inflammation was observed at all. In XCM sites, on the edges of 
the new collagen fibers, few multifocal lymphocytes and plasma cells were visible 
seldom arranged in follicles (Figure 5 g+h). The staining of the epithelium (cytokeratin) 
was strong, the staining of the connective tissue was stronger than that of the native 
tissue and the vessel density was less distinct than at day 15 as observed by the Factor 
VIII staining. 
Histomorphometric analyses 
Thickness of keratin layer and degree of epithelialization (Figure 1 in the appendix) 
The thickness of the keratin layer continuously increased over 29 days. Whereas at day 
4, the majority of the wound surface was not covered by an epithelium, by day 15, the 
entire surface was keratinized (>3 layers). From day 15 to 29, a further maturation of 
the keratin layer occurred. Similarly, the defect area covered with a keratinized 
epithelium continuously increased over 29 days. At day 4, the percentage of the wound 
bed being keratinized was 12.4%±7.5% (control) and 18.0%±10.2% (XCM) and 
increased by roughly a 100% to day 8 (19.7%±25.5% control; 29.1%±8.0% XCM). At 
day 15, almost the entire wound bed was covered with a keratinized epithelium reaching 
values close to 100% without changes up to day 29. 
Quantitative analyses of regenerated tissues 
Area 1 – superficial compartment (Figure 6 a (XCM); Figure 6 b (control)) 
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At baseline, this region was predominantly (>50% occupied by a keratinized epithelium 
and, a dense and a loose connective tissue. From day 4 to day 8, the amount of 
granulation tissue (32% to 88% control; 14% to 41% XCM) increased. In group XCM, 
the remaining collagen matrix made up for 25% and 51%. At day 15 and 29, in both 
groups, the epithelium already occupied more than 50% of area, followed by a loose 
connective tissue. 
Area 2 – central compartment (Figure 2 in the appendix) 
At baseline, a dense connective tissue was the predominant tissue (>70%). At day 4, 
similar to the superficial area, a granulation tissue was the predominant tissue, followed 
by the xenogeneic collagen matrix (XCM). However, there was already a loose 
connective tissue that continuously increased in both groups up to day 15 (84% control; 
62% XCM). The amount of dense connective tissue was higher at all time-points in 
group XCM. 
Area 3 – apical compartment (Figure 3 in the appendix) 
At baseline, the dense connective tissue accounted again for >50% of the area, followed 
by fatty tissue (26%) and a loose connective tissue (15%). At day 4 and 8, the main 
area was occupied by a loose connective tissue (13%/9% control; 25%/43% XCM), a 
dense connective tissue (21%/22% control; 16%/30% XCM) and the remaining 
xenogeneic collagen matrix (10%/8%). At day 29, the tissues were similar to baseline 
with the exception of the missing fatty tissue. 
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DISCUSSION 
The present clinical study demonstrated a favorable tissue integration of a xenogeneic 
collagen matrix and an uneventful healing of control sites without any clinical 
complications during the entire study period. The early phase of wound healing was 
accelerated by the use of a XCM as a wound dressing. This was demonstrated by a 
reduced amount of granulation tissue and a higher degree of epithelialization. At 29 
days, histologic analysis showed a regenerated palatal soft tissue similar to the native 
tissue for both treatment modalities. 
Collagen membranes have been used for years for the purpose of guided tissue 
regeneration (Jung et al., 2013a). Integration and degradation processes of these 
membranes were analyzed using preclinical study designs with histologic outcome 
measures (von Arx et al., 2005). These findings can partially be applied on the more 
recently developed collagen matrices containing fibers of Collagen type I and III from 
the same origin but with a different organization. 
Within the first 48 hours, there is a tissue reaction on the collagen material during the 
process of integration, explained by the presence of inflammatory cells (Rothamel et al., 
2005). This tissue reaction depends on the collagen organization within the devices. The 
closer the collagen organization in the devices mimics natural collagen fiber 
organization, the less pronounced are inflammatory reactions. Nevertheless, within the 
same healing period, an early attachment of epithelial cells and fibroblasts spreading all 
over the xenogeneic collagen matrix was detected, proving biocompatibility of the 
matrix (Willershausen et al., 2014, Ghanaati et al., 2011). During this first phase, the 
matrix was still cell occlusive, similar to a membrane. This was demonstrated by cells 
primarily growing along the surface of the dense matrix layer. The ingrowth pattern of 
endothelial cells and blood vessels into collagen membranes was investigated previously 
(Schwarz et al., 2008, Schwarz et al., 2006). In these studies, collagen membranes 
were implanted without contact to the oral environment. Angiogenesis all through the 
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collagen membrane was shown earliest at 1 week. In the present study with an open 
healing design, collagen matrix degradation patterns were different. Interestingly, 
angiogenesis was observed at a similar time-point (8 days) as demonstrated by 
endothelial cells marked by rabbit anti Factor VIII. This might be explained by the fact 
that these matrices consist of a cell-occlusive superficial layer and a more spongeous 
layer underneath. 
Preclinical data are available for different collagen devices in terms of degradation 
processes with submerged healing protocols or wound healing in contact with the oral 
environment (Vignoletti et al., 2015, Rocchietta et al., 2012, von Arx et al., 2005). In 
an experimental study in cats, collagen matrices were either placed into a pocket for 
submerged healing or were exposed to the oral environment (Tal et al., 2008). Both 
modalities healed uneventfully, but the degradation process was faster in open healing 
sites. These findings are in line with the present study, demonstrating no remnants of 
the xenogeneic collagen matrix at 15 days and a fast regeneration of the connective 
tissue and the epithelium. Inter-individual differences, however, were observed with 
some volunteers presenting a faster healing than others. This might be attributed to the 
fact that the protective splint provided to the volunteers and instructed to be used 
during the first day and in case of pain, was not used on a regular and standardized 
basis. Some volunteers might have used the stent for a day, whereas others made use 
of the splint for an even longer period of time. The influence of wearing a protective 
splint on the early healing remains uncertain as this was not evaluated, but would have 
affected both, control and test sites.  
In terms of keratinization of the wound, XCM sites reached roughly 30% more 
keratinized tissue at day 4 and 8. However, the differences between the groups at these 
time-points were small. At day 15, the surface in all sites was keratinized. Due to the 
selection of the time-points of biopsy harvesting and the limited number of biopsies 
obtained, the present results cannot fully formulate a trend in terms of the 
keratinization process. Further investigations using the same experimental design are 
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needed to evaluate the extent of keratinization at 10-12 days after surgery. A positive 
effect of a prototype XCM on keratinization has previously been found in vitro (Nocini et 
al., 2013). The effect was explained on a molecular basis with the expression of 
Interleukin-6 (Il-6) by keratinocytes when attaching to the collagen fibrils of the matrix. 
Il-6 acts as an anti-apoptosis molecule, protecting the cells of their spontaneous 
apoptosis, thereby accelerating the colonization. 
The quantitative analysis in the present study revealed no differences between the 
groups in the apical compartment, consisting mainly of connective and fatty tissue. The 
amount of connective and fatty tissue in this compartment remained unchanged during 
the entire study period in both groups. Probably, this compartment was only partially 
removed when the first biopsy was harvested. The XCM mainly influenced the wound 
healing superficially by facilitating epithelial cell migration. The greatest differences 
between XCM and spontaneous healing sites were found in the superficial and central 
compartment. Most remarkably, at day 4 as well as at day 8, more granulation tissue 
was formed in sites without a collagen matrix. The percentage of residual collagen 
matrix corresponded to the reduced amount of granulation tissue in both compartments 
at both time-points. Since the cellular processes of early angiogenesis and cell migration 
within the matrix are not fully understood yet, this finding might be an explanation for 
the accelerated wound healing within the first days. In general, wound healing can be 
divided into three stages, inflammation, tissue formation and tissue remodeling (Singer 
and Clark, 1999). In the early phase of an open wound, the body’s primary objective is 
to obtain a seal against outside to prevent the invasion of microorganisms. As a normal 
act of quickest possible wound closure, granulation tissue formation occurs. 
Subsequently, the phases of tissue formation and tissue remodeling finally lead to a 
regeneration and/or reparation of the lesion. This means, that the granulation tissue 
subsequently needs to be reorganized and rebuilt during the second and the third 
phase. Assuming that the xenogeneic collagen matrix acts as a matrix (spongeous 
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layer) for subsequent cell ingrowth and connective tissue formation, it could, at an early 
stage, reduce granulation tissue formation, and secondly facilitate tissue formation. 
The translation of the obtained histological findings into the clinics suggests that the 
application of a collagen matrix as a seal for open palatal wound might be beneficial. 
This is primarily related to the early stages of wound healing (4 and 8 days). Similar 
findings were obtained in an earlier study (Thoma et al., 2012). Furthermore, clinical 
studies demonstrated a good color adaption (Schmitt et al., 2015, Sanz et al., 2009). 
However, data in terms of patient-reported outcome measures assessing general 
morbidity remain scarce in the literature. Less postoperative sensitivity was detected at 
4 and 8 days when the xenogeneic collagen matrix was applied. Morbidity, however, 
was assessed locally (Thoma et al., 2012). 
  19 
CONCLUSIONS 
The application of a xenogeneic collagen matrix (XCM) as a wound dressing on palatal 
wounds might be beneficial during the early stages of wound healing. This finding was 
predominantly observed at 4 and 8 days after surgery and might be due to the space 
maintenance of the XCM and less granulation tissue formation compared to 
spontaneously healing sites. However, further research with a larger sample size is 
needed to confirm these results obtained by an experimental design. 
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Figure Legend 
Figure 1 a + b Punch biopsy harvesting by means of a digitally designed stent (left) and 
illustrative picture taken after harvesting the first biopsy with a diameter of 6 mm and 
application of the collagen matrix (right). The stent for the second biopsy with a 
diameter of 8 mm will allow the removal of the wound margins of the primary lesion. 
Figure 2 Region of interest (ROI) (green rectangle) positioned along the surface of the 
harvested biopsy (collagen matrix=XCM), containing a superficial, central and apical 
compartment. DCT = dense connective tissue; LCT = loose connective tissue; E= 
epithelium; FT = fatty tissue; GT = granulation tissue; KL = keratinized layer. 
Figure 3 Immunohistochemical staining with endothelial cells marked by Factor VIII at 
day 8. Test site (XCM=collagen matrix; a) and control site (b). BV= blood vessel; E = 
Epithelium; MSL= matrix, spongeous layer. 
Figure 4 Biopsy containing native tissue of a test site (XCM=collagen matrix). A 
matured epithelium (E) and keratinized layer (KL), high amounts of dense connective 
tissue (DCT) and fatty tissue (FT) and low amounts of loose connective tissue (LCT) are 
visible. 
Figure 5 a-h At 4 days, the collagen matrix (a) is already well integrated, whereas 
spontaneous healing (b) shows high amounts of granulation tissue (GT) superficially. A 
distinct wound margin towards the keratinized epithelium (E) is visible. The spongeous 
layer of the matrix (MSL) shows an ingrowth of GT, the dense layer (MDL) is clearly 
stained. At 8 days, there are still remnants of the matrix visible (c) compared to a higher 
amount of GT at spontaneously healing sites (d). Wound margins are less distinct and an 
ingrowth of E is visible. Loose connective tissue (LCT) formation takes place in the 
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central compartment. At 15 days, a continuous keratinized layer (KL) covers the newly 
structured loose connective tissue (LCT) in the sites with a collagen matrix (e) as well as 
in the spontaneously healed sites (f). At 29 days, both, the site treated with a collagen 
matrix (g) and the spontaneously healed site (h) show a further maturation of E and KL. 
Apart of the lower amount of dense connective tissue (DCT), compensated by a higher 
amount of loose connective tissue (LCT), there are only minor differences compared to 
the native tissue in Figure 4. 
 
Figure 6 a+b Histomorphometric results of the collagen matrix group (left) and of the 
spontaneous healing group (right) in the superficial compartment at the 5 different time-
points. 
 
Figure 1 Appendix Boxplots illustrating the amount of keratinization in % evaluated at 
the four different time-points after the first biopsy. The surface was considered to be 
keratinized if at least 3 layers were present. XCM= xenogeneic collagen matrix; C= 
control, spontaneous healing. 
 
Figure 2 a+b Appendix Histomorphometric results of the collagen matrix group (left) 
and of the spontaneous healing group (right) in the central compartment at the 5 
different time-points. 
 
Figure 3 a+b Appendix Histomorphometric results of the collagen matrix (left) and the 
spontaneous healing group (right) in the apical compartment at the 5 different time-
points. 
  23 
REFERENCES 
 
Cairo, F., Nieri, M. & Pagliaro, U. (2014) Efficacy of periodontal plastic surgery 
procedures in the treatment of localized facial gingival recessions. A systematic 
review. Journal of Clinical Periodontology 41 Suppl 15, S44-62. 
doi:10.1111/jcpe.12182. 
Cardaropoli, D., Tamagnone, L., Roffredo, A. & Gaveglio, L. (2012) Treatment of gingival 
recession defects using coronally advanced flap with a porcine collagen matrix 
compared to coronally advanced flap with connective tissue graft: a randomized 
controlled clinical trial. Journal of Periodontology 83, 321-328. 
doi:10.1902/jop.2011.110215. 
Ghanaati, S., Schlee, M., Webber, M. J., Willershausen, I., Barbeck, M., Balic, E., 
Gorlach, C., Stupp, S. I., Sader, R. A. & Kirkpatrick, C. J. (2011) Evaluation of the 
tissue reaction to a new bilayered collagen matrix in vivo and its translation to 
the clinic. Biomed Mater 6, 015010. doi:10.1088/1748-6041/6/1/015010. 
Griffin, T. J., Cheung, W. S., Zavras, A. I. & Damoulis, P. D. (2006) Postoperative 
complications following gingival augmentation procedures. Journal of 
Periodontology 77, 2070-2079. 
Harris, R. J., Miller, R., Miller, L. H. & Harris, C. (2005) Complications with surgical 
procedures utilizing connective tissue grafts: a follow-up of 500 consecutively 
treated cases. International Journal of Periodontics and Restorative Dentistry 25, 
449-459. 
Jung, R. E., Fenner, N., Hammerle, C. H. & Zitzmann, N. U. (2013a) Long-term outcome 
of implants placed with guided bone regeneration (GBR) using resorbable and 
non-resorbable membranes after 12-14 years. Clinical Oral Implants Research 
24, 1065-1073. doi:10.1111/j.1600-0501.2012.02522.x. 
Jung, R. E., Hurzeler, M. B., Thoma, D. S., Khraisat, A. & Hammerle, C. H. (2011) Local 
tolerance and efficiency of two prototype collagen matrices to increase the width 
  24 
of keratinized tissue. Journal of Clinical Periodontology 38, 173-179. 
doi:10.1111/j.1600-051X.2010.01640.x. 
Jung, R. E., Philipp, A., Annen, B. M., Signorelli, L., Thoma, D. S., Hammerle, C. H., 
Attin, T. & Schmidlin, P. (2013b) Radiographic evaluation of different techniques 
for ridge preservation after tooth extraction: a randomized controlled clinical trial. 
Journal of Clinical Periodontology 40, 90-98. doi:10.1111/jcpe.12027. 
Kim, D. M. & Neiva, R. (2015) Periodontal soft tissue non-root coverage procedures: a 
systematic review from the AAP regeneration workshop. Journal of Periodontology 
86, S56-72. doi:10.1902/jop.2015.130684. 
Levine, R. A., Huynh-Ba, G. & Cochran, D. L. (2014) Soft tissue augmentation 
procedures for mucogingival defects in esthetic sites. International Journal of Oral 
and Maxillofacial Implants 29 Suppl, 155-185. 
doi:10.11607/jomi.2014suppl.g3.2. 
Liu, J., Bian, Z., Kuijpers-Jagtman, A. M. & Von den Hoff, J. W. (2010) Skin and oral 
mucosa equivalents: construction and performance. Orthod Craniofac Res 13, 11-
20. doi:10.1111/j.1601-6343.2009.01475.x. 
Lorenzo, R., Garcia, V., Orsini, M., Martin, C. & Sanz, M. (2012) Clinical efficacy of a 
xenogeneic collagen matrix in augmenting keratinized mucosa around implants: a 
randomized controlled prospective clinical trial. Clinical Oral Implants Research 
23, 316-324. doi:10.1111/j.1600-0501.2011.02260.x. 
Nevins, M., Nevins, M. L., Kim, S. W., Schupbach, P. & Kim, D. M. (2011) The use of 
mucograft collagen matrix to augment the zone of keratinized tissue around 
teeth: a pilot study. International Journal of Periodontics and Restorative 
Dentistry 31, 367-373. 
Nocini, P. F., Zanotti, G., Castellani, R., Grasso, S., Cristofaro, M. G. & De Santis, D. 
(2013) Bi-layered collagen nano-structured membrane prototype (collagen matrix 
10826((R))) for oral soft tissue regeneration: an "in vitro" study. Clinical Oral 
Implants Research 24, 612-617. doi:10.1111/j.1600-0501.2012.02427.x. 
  25 
Rocchietta, I., Schupbach, P., Ghezzi, C., Maschera, E. & Simion, M. (2012) Soft tissue 
integration of a porcine collagen membrane: an experimental study in pigs. 
International Journal of Periodontics and Restorative Dentistry 32, e34-40. 
Rothamel, D., Schwarz, F., Sager, M., Herten, M., Sculean, A. & Becker, J. (2005) 
Biodegradation of differently cross-linked collagen membranes: an experimental 
study in the rat. Clinical Oral Implants Research 16, 369-378. 
doi:10.1111/j.1600-0501.2005.01108.x. 
Rotundo, R. & Pini-Prato, G. (2012) Use of a new collagen matrix (mucograft) for the 
treatment of multiple gingival recessions: case reports. International Journal of 
Periodontics and Restorative Dentistry 32, 413-419. 
Sanz, M., Lorenzo, R., Aranda, J. J., Martin, C. & Orsini, M. (2009) Clinical evaluation of 
a new collagen matrix (Mucograft prototype) to enhance the width of keratinized 
tissue in patients with fixed prosthetic restorations: a randomized prospective 
clinical trial. Journal of Clinical Periodontology 36, 868-876. doi:10.1111/j.1600-
051X.2009.01460.x. 
Schmitt, C. M., Moest, T., Lutz, R., Wehrhan, F., Neukam, F. W. & Schlegel, K. A. (2015) 
Long-term outcomes after vestibuloplasty with a porcine collagen matrix 
(Mucograft ) versus the free gingival graft: a comparative prospective clinical 
trial. Clinical Oral Implants Research. doi:10.1111/clr.12575. 
Schmitt, C. M., Tudor, C., Kiener, K., Wehrhan, F., Schmitt, J., Eitner, S., Agaimy, A. & 
Schlegel, K. A. (2013) Vestibuloplasty: porcine collagen matrix versus free 
gingival graft: a clinical and histologic study. Journal of Periodontology 84, 914-
923. doi:10.1902/jop.2012.120084. 
Schwarz, F., Rothamel, D., Herten, M., Sager, M. & Becker, J. (2006) Angiogenesis 
pattern of native and cross-linked collagen membranes: an immunohistochemical 
study in the rat. Clinical Oral Implants Research 17, 403-409. 
doi:10.1111/j.1600-0501.2005.01225.x. 
Schwarz, F., Rothamel, D., Herten, M., Wustefeld, M., Sager, M., Ferrari, D. & Becker, J. 
(2008) Immunohistochemical characterization of guided bone regeneration at a 
  26 
dehiscence-type defect using different barrier membranes: an experimental study 
in dogs. Clinical Oral Implants Research 19, 402-415. doi:10.1111/j.1600-
0501.2007.01486.x. 
Simion, M., Rocchietta, I., Fontana, F. & Dellavia, C. (2012) Evaluation of a resorbable 
collagen matrix infused with rhPDGF-BB in peri-implant soft tissue augmentation: 
a preliminary report with 3.5 years of observation. International Journal of 
Periodontics and Restorative Dentistry 32, 273-282. 
Singer, A. J. & Clark, R. A. (1999) Cutaneous wound healing. New England Journal of 
Medicine 341, 738-746. doi:10.1056/NEJM199909023411006. 
Tal, H., Kozlovsky, A., Artzi, Z., Nemcovsky, C. E. & Moses, O. (2008) Cross-linked and 
non-cross-linked collagen barrier membranes disintegrate following surgical 
exposure to the oral environment: a histological study in the cat. Clinical Oral 
Implants Research 19, 760-766. 
Thoma, D. S., Benic, G. I., Zwahlen, M., Hammerle, C. H. & Jung, R. E. (2009) A 
systematic review assessing soft tissue augmentation techniques. Clinical Oral 
Implants Research 20 Suppl 4, 146-165. doi:10.1111/j.1600-
0501.2009.01784.x. 
Thoma, D. S., Buranawat, B., Hammerle, C. H., Held, U. & Jung, R. E. (2014) Efficacy of 
soft tissue augmentation around dental implants and in partially edentulous 
areas: a systematic review. Journal of Clinical Periodontology 41 Suppl 15, S77-
91. doi:10.1111/jcpe.12220. 
Thoma, D. S., Jung, R. E., Schneider, D., Cochran, D. L., Ender, A., Jones, A. A., 
Gorlach, C., Uebersax, L., Graf-Hausner, U. & Hammerle, C. H. (2010) Soft tissue 
volume augmentation by the use of collagen-based matrices: a volumetric 
analysis. Journal of Clinical Periodontology 37, 659-666. doi:10.1111/j.1600-
051X.2010.01581.x. 
Thoma, D. S., Sancho-Puchades, M., Ettlin, D. A., Hammerle, C. H. & Jung, R. E. (2012) 
Impact of a collagen matrix on early healing, aesthetics and patient morbidity in 
  27 
oral mucosal wounds - a randomized study in humans. Journal of Clinical 
Periodontology 39, 157-165. doi:10.1111/j.1600-051X.2011.01823.x. 
Vignoletti, F., Nunez, J., de Sanctis, F., Lopez, M., Caffesse, R. & Sanz, M. (2015) 
Healing of a xenogeneic collagen matrix for keratinized tissue augmentation. 
Clinical Oral Implants Research 26, 545-552. doi:10.1111/clr.12441. 
von Arx, T., Broggini, N., Jensen, S. S., Bornstein, M. M., Schenk, R. K. & Buser, D. 
(2005) Membrane durability and tissue response of different bioresorbable barrier 
membranes: a histologic study in the rabbit calvarium. International Journal of 
Oral and Maxillofacial Implants 20, 843-853. 
Wessel, J. R. & Tatakis, D. N. (2008) Patient outcomes following subepithelial connective 
tissue graft and free gingival graft procedures. Journal of Periodontology 79, 425-
430. 
Willershausen, I., Barbeck, M., Boehm, N., Sader, R., Willershausen, B., Kirkpatrick, C. 
J. & Ghanaati, S. (2014) Non-cross-linked collagen type I/III materials enhance 
cell proliferation: in vitro and in vivo evidence. J Appl Oral Sci 22, 29-37. 
doi:10.1590/1678-775720130316. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 
 
 
 
 
 
 
 
 
 
 
Figure 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix 3 
 
 
